Financial reports
10-Q
2010 Q2
Quarterly report
6 Aug 10
10-Q
2010 Q1
Quarterly report
10 May 10
10-K/A
2009 FY
Annual report (amended)
29 Apr 10
10-K
2009 FY
Annual report
16 Mar 10
10-Q
2009 Q3
Quarterly report
9 Nov 09
10-Q
2009 Q2
Quarterly report
10 Aug 09
10-Q
2009 Q1
Quarterly report
11 May 09
ARS
2008 FY
Annual report to shareholders
1 May 09
10-K/A
2008 FY
Annual report (amended)
29 Apr 09
10-K
2008 FY
Annual report
16 Mar 09
Current reports
8-K
Penwest Pharmaceuticals Announces Intention to Terminate Nasdaq Listing and Registration
15 Oct 10
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Oct 10
8-K
Penwest Pharmaceuticals Sets Special Shareholders Meeting Date for Approval of Merger with Subsidiary of Endo Pharmaceuticals
1 Oct 10
8-K
Changes in Control of Registrant
20 Sep 10
8-K
Penwest Pharmaceuticals Agrees to Be Acquired by Endo Pharmaceuticals for $5.00 Per Share In Cash
10 Aug 10
8-K
Penwest Reports Record Revenue and Earnings for Second Quarter of 2010
4 Aug 10
8-K/A
Submission of Matters to a Vote of Security Holders
6 Jul 10
8-K
Submission of Matters to a Vote of Security Holders
25 Jun 10
8-K
Entry into a Material Definitive Agreement
14 Jun 10
8-K
Penwest Reports First Quarter 2010 Financial Results
3 May 10
Registration and prospectus
15-12B
Securities registration termination
9 Nov 10
15F-12B
Securities registration termination (foreign)
4 Nov 10
POS AM
Prospectus update (post-effective amendment)
29 Oct 10
POS AM
Prospectus update (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Oct 10
Proxies
DEF 14A
Definitive proxy
1 Oct 10
PRER14A
Preliminary revised proxy
24 Sep 10
PREM14A
Preliminary proxy related to merger
7 Sep 10
DEFA14A
Additional proxy soliciting materials
17 Jun 10
DEFA14A
Additional proxy soliciting materials
14 Jun 10
DEFA14A
Additional proxy soliciting materials
14 Jun 10
DEFA14A
Additional proxy soliciting materials
14 Jun 10
DEFA14A
Additional proxy soliciting materials
14 Jun 10
DFAN14A
Additional proxy materials by non-management
14 Jun 10
DFAN14A
Additional proxy materials by non-management
11 Jun 10
Other
UPLOAD
Letter from SEC
12 Apr 11
EFFECT
Notice of effectiveness
1 Nov 10
EFFECT
Notice of effectiveness
1 Nov 10
CT ORDER
Confidential treatment order
14 Oct 10
UPLOAD
Letter from SEC
5 Oct 10
CORRESP
Correspondence with SEC
24 Sep 10
UPLOAD
Letter from SEC
15 Sep 10
CT ORDER
Confidential treatment order
20 Aug 10
UPLOAD
Letter from SEC
27 May 10
UPLOAD
Letter from SEC
17 May 10
Ownership
SC 13D/A
PERCEPTIVE ADVISORS LLC
27 Sep 10
SC 13D/A
TANG CAPITAL PARTNERS LP
27 Sep 10
SC 13D
ENDO PHARMACEUTICALS HOLDINGS INC
20 Sep 10
SC 13D/A
PERCEPTIVE ADVISORS LLC
23 Aug 10
SC 13D/A
PERCEPTIVE ADVISORS LLC
11 Aug 10
SC 13D/A
TANG CAPITAL PARTNERS LP
10 Aug 10
SC 13D/A
PERCEPTIVE ADVISORS LLC
1 Jul 10
SC 13D/A
TANG CAPITAL PARTNERS LP
30 Jun 10
11-K
Annual report of employee stock purchases
17 Jun 10
SC 13D/A
PERCEPTIVE ADVISORS LLC
28 May 10